Two transfer factors have been prepared in an animal model system, the guinea pig. They are both small molecules, derived from the leukocytes of immunologically experienced individuals, and capable of transferring information for specific immune responses to naive individuals.
The molecular events involved in the development of an immune response represent a largely unsolved problem. Numerous steps intervene between the introduction of antigen and the mounting of the full immune response. These steps often include the production of macromolecular mediators, which serve as signals between the participating cells.
Transfer factors are a controversial example of molecules that mediate immunological information. They are subcellular components, derived from the leukocytes of an educated individual, that can be used to transmit immunological information to a naive individual (1, 2) .
The transfer factor phenomenon arose in 1954 from the work of Lawrence with human beings (3) and of Jeter, Tremaine, and Seebohm with guinea pigs (4) . Their experiments began with individuals who were exposed to antigens such as streptococcal protein or dinitrochlorobenzene. This exposure provoked a primary immune response that not only eliminated the foreign agent but also established a long-lived memory within the immune system. Thus, when the animals were exposed again to antigen, they mounted a secondary response that was both stronger and more rapid than the primary response.
The key observation of Lawrence, and of Jeter, Tremaine, and Seebohm, was that extracts prepared from the leukocytes of the sensitized individuals contained a substance that could transmit immunological memory (or preparedness) to a naive individual. Thus, the naive individual, upon receipt of the leukocyte extract, could immediately mount a secondary immune response upon hisfirst exposure to the antigen.* In subsequent years the transfer factor phenomenon was extended to include several other immune reactions; for instance, responses against transplantation antigens (5), bacterial spores (6, 7) , and such foreign proteins as tuberculin Abbreviations: DNCB, 1-chloro-2,4-dinitrobenzene; OCBC, ortho-chlorobenzoylchloride. *This is the traditional definition of transfer factor. In the more recent literature, the term "transfer factor" has been increasingly used to refer to any leukocyte-derived material that can elicit an immune system-related response. As the nature of these substances and the responses they elicit becomes further understood, it may be advisable to assign independent names to the substances involved. 2473 (8) , diphtheria toxin (9) , and modified serum components (10) .
All of these immune responses have in common the property that they are "cell-mediated." That is, they can be directly carried out by intact leukocytes, as opposed to leukocytes that function indirectly through the secretion of freely circulating antibodies. Whether or not there are similar transfer factors associated with humoral immune responses remains unknown.
Transfer factors are of interest, not only because of their promise in helping to understand the mechanisms involved in the immune response, but also because of their potential application in the treatment of diseases. For instance, transfer factors have been used with encouraging results in a variety of immunodeficiency diseases (11), infections (7) , and neoplasias (12) .
The physical identity of the transfer factors has been a problem of long-standing interest. Lawrence has shown that human transfer factor is resistant to DNase, pancreatic RNase, and trypsin (13) . He has also made the important observation that the transfer factors are small enough to pass through a dialysis membrane (14) . This finding poses an interesting problem, for it means that the transfer factors are too small either to be or to code for the proteins involved in a specific immune response. A regulatory role for transfer factor appears to be indicated.
We have studied the transfer factor phenomenon in guinea pigs, drawing on the procedures introduced by Jeter, Burger, Tremaine, and Seebohm (4, 15) and by Guthrie, Ellis, and Brock (16) . The general purpose of the experiments is 2-fold: to further characterize the reaction mediated by transfer factor, and to attempt to inactivate the transfer factor enzymatically and, thereby, determine its chemical nature.
As discussed in this paper The delayed hypersensitivity response is characterized by several stages of increasing severity. We score the reactions as in Chart 1.
On the sixth day after sensitization, the animals were tested to show that they had become able to give the above delayed hypersensitivity response. The backs of the animals were shaved with an electric clipper (Oster, blade no. 40). The remaining hair was then removed with Neet, a commercial depilatory. Thirty-five microliters of 50 mM )NCB3 (or 700 mM\1 OCBC), dissolved in a 1:1 mixture of acetone and olive oil, was then applied to the shaved backs of the animals. The result of the sensitization was that the guinea pigs uniformly gave a strong +2 response, as shown in Fig. 1 and in the related close-up, Fig. 2A The DNCB-and OCBC-sensitized animals were used as the source of transfer factor. For a standard preparatioii, three animals were processed. Oin day 7, each animal was injected intraperitoneally with 25 ml of heavy paraffin oil. This was done in order to induce a nonspecific irritation of the peritoneal cavity (peritonitis) which would result in an] increased concentration of leukocytes in the abdominal cavity. FIGS. 1-5 (on preceding page).
In this paper we study, in guinea pigs, the phenomenon of transfer factor-that is, the transmission of specific immunological information from a population of "educated" leukocytes to a population of "naive" leukocytes. The figures show the type of immune responsiveness that is present in the sensitized donors and that can be transmitted to naive recipients by transfer factor.
FIG. 1. Immune capacity developed in an animal that has been directly exposed to antigen (DNCB or OCBC). Six days after antigen was painted on the ear, the back of the guinea pig was shaved and the antigen was applied again. This provoked the secondary response (a delayed hypersensitivity reaction) shown. The reaction is designated +2 in severity; it is characterized by a homogeneous erythema (redness) which represents an increased blood supply in the area where responding leukocytes are eliminating the antigen. animal that was mock injected with a saline solution. Upon challenge with DNCB (which here is the first exposure to antigen) the two test animals both mounted secondary responses. The animal on the left, which received the transfer factor from one-fourth of a donor, was able to produce very strong delayed hypersensitivity responses upon challenge with antigen. The reactions are scored as +5, being characterized by homogeneous necrosis of the affected region, in addition to erythema and induration (swelling). The middle animal received transfer factor from one-eighth of a donor and was able to give a +4 response (patchy necrosis) to the higher test solution of antigen used, and a +3 response (erythema and induration) to the lower test solution of antigen. (The slight erythema on the tipper left flanks of the test animals was in response to a very low concentration of antigen, 5 mMf DNCB.) The control animal on the right, which received saline solution instead of transfer factor, was not able to give a response upon challenge with antigen.
FIG. 4. D)ata concerning the specificity of the immune responsiveness transmitted by transfer factor. This animal has been injected
with transfer factor prepared from donors that had been sensitized to give a delayed hypersensitivity response to OCBC. The animal that received the transfer factor was then challenged with both DNCB and OCBC; he responded only to OCBC (upper flank). The response is +3 in severity (erythema and induration). FIG. 5 . The swelling component of the reaction in Fig. 4 is particularly well displayed here, where the reaction site has been pinched.
Transfer Factor
Immunology: Rosenfeld and Dressier
On day 11, the animals were sacrificed, using ether and cervical dislocation. A small incision, about 2 cm in diameter, was then made in the abdominal wall and 50 ml of Hank's balanced salt solution was introduced into the peritoneal cavity. With intermittent massaging of the abdominal walls to distribute the fluid, the suspension of oil and Hank's solution was pipetted into centrifuge tubes on ice. In this way leukocytes were washed off the peritoneal wall and the surrounding viscera. The process was repeated with a second 50-ml portion of Hank's solution. The suspension of peritoneal exudate cells was spun at 1500 rpm in the Sorvall HB-4 rotor for 10 min at 4°. The cell pellet was resuspended in 5 ml of Hank's solution and kept on ice.
The abdominal incision was then enlarged and the spleen was removed and placed on ice in a petri dish containing Hank's solution. The spleen was cut into about 10 pieces and homogenized with a Dounce homogenizer, using 5 ml of Hank's solution. The insoluble fibrous residue was allowed to settle and was discarded.
Finally the lungs were removed. They were placed in a petri dish on ice with 5 ml of Hank's solution, and minced with surgical scissors. Alveolar leukocytes were washed free by gently squeezing the minced tissue in the buffer. The remainder of the lung tissue was discarded.
The peritoneal cell suspension, the spleen homogenate, and the alveolar wash were pooled. The cells were then centrifuged as described above and resuspended in 7.5 ml of Hank's solution. They were then incubated at 370 for 4.5 hr on a roller drum, a procedure introduced by Guthrie, Ellis, and Brock (16) . After 1 hr of incubation a cell count was made, showing a density of about 108 cells per ml. The majority of the cells were leukocytes.
After 4.5 hr, the cell suspension was again centrifuged, as described above. The supernatant was collected and dialyzed for 20 hr against 200 ml of 150 mM NaCl and 5 mM Tris buffer, pH 8. The dialysate was lyophilized to dryness and weighed, giving a final mass of about 2.0 g from the original three guinea pigs. About 1.8 g of this mass could be attributed to the NaCl in the dialysis buffer.
The preparation was dissolved in 5 ml of distilled water and stored frozen.
Assay of the transfer factor preparations
The lyophilized dialysates were tested to see if they contained transfer factor activity-that is, if they could transfer to animals that had never been exposed to DNCB or OCBC the ability to give a delayed hypersensitivity response upon first exposure to the antigen. Fig. 3 shows results that were typical for the transfer factor preparations. Three naive animals were injected intraperitoneally: Animals on the left and in the middle received 0.5 ml and 0.25 ml of DNCB transfer-factor preparation, respectively; the control animal (on the right) received 0.5 ml of 3 M NaCl. The use of 0.25 ml of the transfer factor preparation represented an attempt to sensitize a recipient with the material from about 15% of an original sensitized donor. Fortyeight hours after injection, the animals were shaved and challenged on the upper flank with 35 yI of 50 mMdlDNCB in acetone-olive oil. A second challenge site on the lower flank received a lower concentration of DNCB (25 mM).
Responses began to appear 10-14 hr after challenge. It was clearly evident by 18 hr that the animals that had received transfer factor had developed pronounced +3 responses, characterized by erythema (redness) and induration (swelling). By 36 hr, the guinea pig that had received 0.5 ml of transfer factor (left) showed +5 reactions (homogeneous necrosis) to both the higher and lower test solutions of DNCB. The animal that had received 0.25 ml of transfer factor (middle) showed a +4 response to the higher concentration of DNCB and a +3 response to the lower DNCB concentration.
Because of the time course of appearance of these responses, we have accepted them to be delayed hypersensitivity reactions.
The naive control animal (right), which had been injected with 0.5 ml of a 3 M NaCl solution rather than transfer factor gave no response whatsoever to challenge with DNCB. Thus, the concentrations of DNCB used for challenging, and the procedures involved, were not in themselves irritating.
The delayed hypersensitivity responses mediated by the OCBC transfer factor preparations were identical to those described above. 4 presents data indicating that the transfer f tctors transmit information for specific immune reactions.
Two naive animals were injected, one with OCBC transfer factor and the other with DNCB transfer factor (not shown). Forty-eight hours later both animals were challenged simultaneously with 35 Ml of 700 mMI OCBC (on the upper flank) and 50 mM DNCB (on the lower flank). The animal injected with OCBC transfer factor responded only to challenge with OCBC and gave no response to DNCB; conversely, the guinea pig that received DNCB transfer factor mounted a full response to challenge with DNCB but did not respond to OCBC. Specificity experiments such as the one above have been performed on four independent DNCB3 and OCIBC transfer factor preparations.
Summary
As first described by Lawrence How certain can we be that the transfer factor phenomenon is real? Throughout its history, transfer factor has been a matter of considerable dispute; a critical review of the developing data can be found in ref. 17 . We believe that we have seen the transfer factor phenomenon in at least 20 independent preparations. The reactions observed were pronounced, and exactly as shown in Figs. 3-5 . On the four occasions when we simultaneously tested DNCB and OCBC transfer factor preparations for the specificity of the immunological information they transmitted to naive individuals, the results clearly indicated specificity. All of the steps in the preparation and testing of transfer factor have been done both collaboratively and independently by each of the present authors and by Huntington Potter, who has joined our research group. Our major problem is the fact that, at least in our hands, the preparation of transfer factor is a matter of chance, occurring with a success rate of 30%. This clearly means that the isolation of biologically active transfer factor depends on variables that are not yet understood and are therefore not adequately described in the procedures section. Our current efforts are largely directed toward finding a solution to this problem.
Using these transfer factor preparations, we have performed an enzymological analysis that indicates that the biological activity of transfer factor is contained partly or entirely in low molecular weight, double-stranded RNA molecules. Also, we have been able to measure the size of the transfer factors on polyacrylamide gels. These results will be presented in two succeeding papers (18; H. Potter and D. Dressler, manuscript in preparation), and in considering them we will discuss some of the possible ways in which transfer factors might function as carriers of immunological information.
